Description

AGOBLISS 25 TAB is a prescription medication that contains Agomelatine 25 mg, a modern antidepressant used in the treatment of major depressive disorder (MDD) and associated mood disturbances. Unique in its mechanism of action, Agomelatine works by acting as an agonist at melatonin receptors (MT1 and MT2) and an antagonist at serotonin 5-HT2C receptors. This dual activity helps reset the body’s circadian rhythm, improve sleep, and alleviate symptoms of depression without the typical side effects associated with conventional antidepressants.

AGOBLISS 25 TAB is suitable for adults suffering from depression-related insomnia, lack of motivation, sadness, anxiety, and fatigue. It is well-tolerated and has minimal sexual or weight-related side effects, making it a preferred choice for long-term depression management.

• Agomelatine 25 mg – Melatonergic agonist and 5-HT2C antagonist

• Major depressive disorder (MDD)

• Depression with insomnia

• Mood disorders and circadian rhythm disturbances

• Stress-related mental fatigue

• Resynchronizes sleep-wake cycles disturbed by depression

• Enhances mood, motivation, and daily functioning

• Non-sedating and free from withdrawal symptoms

• Minimal impact on sexual function and weight

• Suitable for long-term depression management

• Well-tolerated in adult populations

Agomelatine mimics melatonin to reset the body clock (circadian rhythm) and blocks 5-HT2C receptors, which enhances dopamine and norepinephrine release in the frontal cortex. This dual action improves both sleep quality and mood regulation—two key factors in managing depression effectively.

• Typically one tablet (25 mg) taken orally at bedtime

• Can be increased to 50 mg/day under medical supervision

• Should be taken at the same time every night

• Do not exceed the recommended dose

• Not suitable for patients with liver impairment

• Regular liver function monitoring required during treatment

• Avoid alcohol and other CNS depressants

• Not recommended during pregnancy or breastfeeding unless advised

• Report any signs of jaundice, fatigue, or nausea to your doctor

• Headache, dizziness, nausea, or mild gastrointestinal disturbances

• Transient anxiety or vivid dreams

• Elevated liver enzymes (rare) – requires monitoring

• Generally fewer side effects than SSRIs or SNRIs

AGOBLISS 25 TAB is proudly manufactured and distributed by Bluepill Express, a globally recognized pharmaceutical exporter. Specializing in third-party manufacturing and private labeling, Bluepill Express supplies WHO-GMP certified pharmaceutical products to over 140 countries.

• Europe (Western & Eastern)

• Africa (North, Sub-Saharan)

• Middle East and GCC

• Southeast Asia and South Asia

• CIS Nations and Latin America

• Australia and Pacific Islands

• WHO-GMP and ISO-certified manufacturing

• Strict international quality compliance

• Private label and custom branding options available

• Full regulatory support: COA, MSDS, FSC, and other docs

• Fast and reliable export logistics

AGOBLISS 25 TAB represents Bluepill Express’s commitment to mental health and patient well-being. With a strong distribution and support network, Bluepill Express delivers high-quality psychiatric medications to global healthcare providers and distributors.